---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-25-000061"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2025-04-10T23:59:59+00:00"
generated_at: "2026-05-23T16:46:24.967578+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lifecore Biomedical shareholders approve issuance of shares beyond 19.99% threshold

## Summary
- At April 10, 2025 special meeting, stockholders approved the Issuance Proposal, allowing issuance of common stock underlying Series A Preferred Stock in excess of 19.99% of outstanding common shares.
- Votes on Issuance Proposal: 24,098,218 For, 444,639 Against, 33,281 Abstain.
- Adjournment Proposal was also approved (28,882,501 For) but not needed since Issuance Proposal passed.
- The approval relates to the Securities Purchase Agreement dated January 9, 2023, with named investors.

## SEC filing metadata
- accession: 0001005286-25-000061
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2025-04-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000061/0001005286-25-000061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000061/lndc-20250410.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-25-000061
- JSON: https://secwatch.observer/filing/0001005286-25-000061.json
- Plain text: https://secwatch.observer/filing/0001005286-25-000061.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.